We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+20.93%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$237B
AUM Growth
+$24.6B
Cap. Flow
-$17.5B
Cap. Flow %
-7.37%
Top 10 Hldgs %
15.61%
Holding
8,813
New
706
Increased
2,953
Reduced
4,001
Closed
776

Sector Composition

Rank Sector Weight
1 Technology 10.78%
2 Healthcare 6.25%
3 Consumer Discretionary 6.24%
4 Financials 5.99%
5 Communication Services 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCI
8351
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
-19
Closed -$1K
NBIS
8352
PUT
Nebius Group N.V.
NBIS
$57.3B
-10,000
Closed -$341K
ORKA
8353
Oruka Therapeutics
ORKA
$5.92B
-3
Closed
GPUS
8354
Hyperscale Data Inc
GPUS
$59.3M
0
-$3K
EMCS
8355
Xtrackers MSCI Emerging Markets Select ETF
EMCS
$1.01B
-1,924
Closed -$41K
UOKA
8356
DELISTED
MDJM Ltd
UOKA
-2
Closed -$4K
PHLT
8357
DELISTED
Performant Healthcare Inc
PHLT
$0 ﹤0.01%
+706
New +$486
RDGT
8358
Ridgetech Inc
RDGT
$2.62M
-1
Closed -$36K
WHWK
8359
Whitehawk Therapeutics
WHWK
$205M
$0 ﹤0.01%
13
-1,079
-99% -$14.1K
JOYY
8360
CALL
JOYY Inc
JOYY
$3.77B
-15,000
Closed -$799K
GXDW
8361
Global X Funds Global X Dorsey Wright Thematic ETF
GXDW
$6.32M
-324
Closed -$7K
VSA
8362
VisionSys AI
VSA
$8.32M
0
TRPA
8363
Hartford AAA CLO ETF
TRPA
$111M
-4,198
Closed -$161K
TGEN
8364
Tecogen Inc
TGEN
$112M
-1,131
Closed -$1K
YCBD.PRA
8365
DELISTED
cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
-3,683
Closed -$20K
PAVMZ
8366
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
-490
Closed
CSF
8367
DELISTED
VictoryShares US Discovery Enhanced Volatility Wtd ETF
CSF
-1,608
Closed -$52K
PDCO
8368
PUT
DELISTED
Patterson Companies, Inc.
PDCO
-100
Closed -$2K
DM
8369
DELISTED
Desktop Metal, Inc.
DM
-175
Closed -$17K
GSMGW
8370
DELISTED
Cheer Holding, Inc. Warrant expiring 2/13/2025
GSMGW
$0 ﹤0.01%
+1,522
New +$103
SNAX
8371
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
-1,773
Closed -$268K
USAP
8372
DELISTED
Universal Stainless & Alloy
USAP
$0 ﹤0.01%
33
-1,027
-97% -$7.9K
LFLYW
8373
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$0 ﹤0.01%
151
-99
-40% -$50
PFIE
8374
DELISTED
Profire Energy, Inc
PFIE
-905
Closed -$1K
BBSA
8375
DELISTED
JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF
BBSA
-668
Closed -$35K

Similar funds

UBS Group's Q2 2020 Portfolio in Review

As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group withdrew a net $17.5B in Q2 2020, closing 776 positions and reducing 4,001 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.

  • UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
  • UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
  • UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
  • UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
  • UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
  • UBS Group opened 706 new positions and closed 776 in Q2 2020.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.